Developing the next generation of antibiotics with novel mechanisms of action

We are building the most detailed, dynamic, in-silico model of bacterial cell envelope biogenesis, ever assembled. The model is being utilised as a platform to discover and develop an internal pipeline of new antibacterial drugs.


Oppilotech Secures Funding From CARB-X to Fight Drug Resistant Infections